Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 553-558

  Kokate, Tushar G ^a   Yamaguchi, Shun Ichi ^a   Pannell, Lewis K ^b   Rajamani, Umamaheswari ^b   Carroll, David M ^a   Grossman, Andrew B ^a   Rogawski, Michael A ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE; ELTANOLONE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; DRUG TOLERANCE; GABA MODULATORS; MALE; MICE; MOTOR ACTIVITY; PREGNANOLONE;

EID: 0032464027     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Belelli D, Bolger MB and Gee KW (1989) Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol 166:325-329.
2. A receptor. Brain Res 561:157-161.
3. Boisse NR, Quaglietta N, Samoriski GM and Guarino JJ (1990) Tolerance and physical dependence to a short-acting benzodiazepine, midazolam. J Pharmacol Exp Ther 252:1125-1133.
4. A receptor. J Pharmacol Exp Ther 280:1284-1295.
5. Coughenour AG, McLean JR and Parker RB (1977) A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 6:351-353.
6. A receptor regulation: Chronic treatment with pregnanolone uncouples allosteric interactions between steroids and benzodiazepine recognition sites. Mol Pharmacol 44:191-197.
7. Garratt JC, Gent JP, Feely M and Haigh JR (1988) Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential? Eur J Pharmacol 145:75-80.
8. A receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9:207-227.
9. Gee KW, Bolger MB, Brinton RE, Coirini H and McEwen BS (1988) Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246:803-812.
10. Gonsalves SF and Gallager DW (1987) Time course for development of anticonvulsant tolerance and GABAergic subsensitivity after chronic diazepam. Brain Res 405:94-99.
11. Haigh JRM and Feely M (1988) Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci 9:361-366.
12. A receptor complex. J Pharmacol Exp Ther 241:346-353.
13. Herzog AG (1995) Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45:1660-1662.
14. Herzog AG (1996) Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 36:1607-1610.
15. Hogskilde S, Wagner J, Carl P, Anker N, Angelo HR and Sorensen MB (1988) Anticonvulsive properties of pregnanolone emulsion compared with althesin and thiopentone in mice. Br J Anaesth 61:462-467.
16. Kokate TG and Rogawski MA (1997) Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone. Epilepsia 38(Suppl 8):46.
17. Kokate TG, Svensson BE and Rogawski MA (1994) Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270:1223-1229.
18. Levy RH and Wurden CJ (1995) Carbamazepine. Interactions with other drugs, in Antiepileptic drugs, 4th ed, (Levy RH, Mattson RH and Meldrum BS eds), pp 543-554, Raven Press, New York.
19. Löscher W, Rundfeldt C, Hönack D and Ebert U (1996) Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil. J Pharmacol Exp Ther 279:561-572.
20. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38: 379-395.
21. Majewska MD, Harrison NL, Schwartz RD, Barker JL and Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007.
22. Paul SM and Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322.
23. Perrault G, Morel E, Sanger DJ and Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298-303.
24. A receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 94:1257-1269.
25. Reddy DS and Kulkarni SK (1997) Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Methods Find Exp Clin Pharmacol 19:395-405.
26. Rundfeldt C, Wlaz P, Honack D and Loscher W (1995) Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecamil. J Pharmacol Exp Ther 275:693-702.
27. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392:926-930.
28. White HS, Woodhead JH, Franklin MR, Swinyard EA and Wolf HA (1995) General principles. Experimental selection, quantification, and evaluation of antiepileptic drugs, in Antiepileptic Drugs, 4th ed., (Levy RH, Mattson RH and Meldrum BS eds), pp 99-110, Raven Press, New York.
29. Wieland NC, Mirasedeghi S and Gee KW (1991) Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565:263-268.
30. Wildin JD and Pleuvry BJ (1992) Tolerance to the anticonvulsant effects of clobazam in mice. Neuropharmacology 31:129-135.
31. Yu R and Ticku MK (1995a) Chronic neurosteroid treatment produces functional heterologous uncoupling at the γ-aminobutyric acid receptor complex in mammalian cortical neurons. Mol Pharmacol 47:603-610.
32. A receptor complex in mammalian cortical neurons. J Pharmacol Exp Ther 275:784-789.